Onex Canada Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.15M | Hold |
12,268
| – | – | 0.95% | 35 |
|
|
2026
Q1 | $6.03M | Buy |
12,268
+197
| +2% | +$107K | 1% | 30 |
|
|
2025
Q4 | $6.99M | Sell |
12,071
-476
| -4% | -$269K | 0.97% | 32 |
|
|
2025
Q3 | $6.09M | Buy |
12,547
+97
| +0.8% | +$45.1K | 0.77% | 40 |
|
|
2025
Q2 | $5.05M | Buy |
12,450
+294
| +2% | +$123K | 0.62% | 46 |
|
|
2025
Q1 | $6.05M | Sell |
12,156
-35
| -0.3% | -$19K | 0.78% | 43 |
|
|
2024
Q4 | $6.34M | Buy |
12,191
+437
| +4% | +$240K | 0.76% | 38 |
|
|
2024
Q3 | $7.27M | Hold |
11,754
| – | – | 0.85% | 33 |
|
|
2024
Q2 | $6.5M | Buy |
11,754
+80
| +0.7% | +$45.8K | 0.74% | 40 |
|
|
2024
Q1 | $6.79M | Sell |
11,674
-984
| -8% | -$552K | 0.68% | 50 |
|
|
2023
Q4 | $6.72M | Sell |
12,658
-3,854
| -23% | -$1.87M | 0.66% | 53 |
|
|
2023
Q3 | $8.36M | Sell |
16,512
-1,345
| -8% | -$717K | 0.64% | 52 |
|
|
2023
Q2 | $9.32M | Sell |
17,857
-2,695
| -13% | -$1.45M | 0.56% | 58 |
|
|
2023
Q1 | $11.8M | Sell |
20,552
-2,391
| -10% | -$1.35M | 0.65% | 50 |
|
|
2022
Q4 | $12.6M | Buy |
22,943
+3,986
| +21% | +$2.11M | 0.71% | 48 |
|
|
2022
Q3 | $9.62M | Buy |
18,957
+905
| +5% | +$506K | 0.57% | 54 |
|
|
2022
Q2 | $9.81M | Sell |
18,052
-190
| -1% | -$105K | 0.54% | 57 |
|
|
2022
Q1 | $10.8M | Sell |
18,242
-29
| -0.2% | -$16.7K | 0.47% | 66 |
|
|
2021
Q4 | $12.2M | Buy |
18,271
+175
| +1% | +$109K | 0.5% | 61 |
|
|
2021
Q3 | $10.3M | Buy |
18,096
+26
| +0.1% | +$14.3K | 0.43% | 68 |
|
|
2021
Q2 | $9.12M | Buy |
18,070
+62
| +0.3% | +$29.3K | 0.42% | 71 |
|
|
2021
Q1 | $8.22M | Sell |
18,008
-55
| -0.3% | -$26.3K | 0.37% | 80 |
|
|
2020
Q4 | $8.41M | Sell |
18,063
-221
| -1% | -$104K | 0.58% | 62 |
|
|
2020
Q3 | $8.07M | Sell |
18,284
-332
| -2% | -$137K | 0.53% | 63 |
|
|
2020
Q2 | $6.75M | Sell |
18,616
-2,671
| -13% | -$895K | 0.45% | 69 |
|
|
2020
Q1 | $6.04M | Buy |
21,287
+272
| +1% | +$85.8K | 0.4% | 78 |
|
|
2019
Q4 | $6.69M | Sell |
21,015
-140
| -0.7% | -$42.5K | 0.38% | 73 |
|
|
2019
Q3 | $6.16M | Buy |
+21,155
| New | +$6.06M | 0.39% | 67 |
|
|
2015
Q1 | – | Sell |
-425,099
| Closed | -$53.3M | – | 84 |
|
|
2014
Q4 | $53.3M | Buy |
425,099
+182,739
| +75% | +$22.2M | 3.12% | 11 |
|
|
2014
Q3 | $29.5M | Buy |
242,360
+1,680
| +0.7% | +$204K | 2.21% | 20 |
|
|
2014
Q2 | $28.4M | Buy |
240,680
+17,090
| +8% | +$2.01M | 1.92% | 21 |
|
|
2014
Q1 | $26.9M | Buy |
+223,590
| New | +$26.6M | 1.72% | 25 |
|
Other funds holding TMO
Onex Canada Asset Management's TMO Position: Q2 2026 in Review
Onex Canada Asset Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 12,268 shares worth $6.15M. The position accounts for 0.95% of the portfolio, ranked #35.
Onex Canada Asset Management first reported a position in TMO in Q1 2014 and has held it in 32 quarters since. The position peaked at $53.3M in Q4 2014. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Onex Canada Asset Management held 12,268 shares of Thermo Fisher Scientific worth $6.15M as of Q2 2026.
- Onex Canada Asset Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
- Thermo Fisher Scientific made up 0.95% of Onex Canada Asset Management's portfolio in Q2 2026, its #35 holding.
- Onex Canada Asset Management first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 32 quarters since.
- Onex Canada Asset Management's Thermo Fisher Scientific position peaked at $53.3M in Q4 2014.
- 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Onex Canada Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.